Ind-Swift Management

Management Kriterienprüfungen 2/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Gopal Munjal

Geschäftsführender

₹18.0m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	100.0%
Amtszeit als Geschäftsführer	16.3yrs
Eigentum des Geschäftsführers	3.6%
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	16yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Gopal Munjal im Vergleich zu den Einnahmen von Ind-Swift verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Mar 31 2024	n/a	n/a	₹142m
Dec 31 2023	n/a	n/a	₹298m
Sep 30 2023	n/a	n/a	₹437m
Jun 30 2023	n/a	n/a	₹438m
Mar 31 2023	₹18m	₹18m	₹260m
Dec 31 2022	n/a	n/a	-₹318m
Sep 30 2022	n/a	n/a	-₹375m
Jun 30 2022	n/a	n/a	-₹319m
Mar 31 2022	₹18m	₹18m	-₹200m
Dec 31 2021	n/a	n/a	-₹320m
Sep 30 2021	n/a	n/a	-₹272m
Jun 30 2021	n/a	n/a	-₹245m
Mar 31 2021	₹15m	₹15m	-₹298m
Dec 31 2020	n/a	n/a	-₹171m
Sep 30 2020	n/a	n/a	-₹277m
Jun 30 2020	n/a	n/a	-₹254m
Mar 31 2020	₹12m	₹12m	-₹191m
Dec 31 2019	n/a	n/a	-₹4m
Jun 30 2019	n/a	n/a	₹48m
Mar 31 2019	₹12m	₹12m	₹82m
Mar 31 2018	₹12m	₹12m	-₹504m

Vergütung im Vergleich zum Markt: GopalDie Gesamtvergütung ($USD215.75K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD38.34K).

Entschädigung vs. Einkommen: GopalDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Gopal Munjal (66 yo)

16.3yrs

Amtszeit

₹18,000,000

Vergütung

Dr. Gopal Munjal, M.D. has been the Chief Executive Officer and Managing Director of Ind-Swift Ltd. since April 2008. Dr. Munjal has experience in Pharmaceutical industry.Dr. Munjal served as the Chairman...

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Sanjeev Mehta	Executive Chairman	17.7yrs	₹18.00m	3.76% ₹ 43.9m
Gopal Munjal	CEO, MD & Whole Time Director	37.6yrs	₹18.00m	3.61% ₹ 42.2m
Vikrant Mehta	Joint MD & Whole Time Director	30.8yrs	₹18.00m	3.55% ₹ 41.4m
Navrattan Munjal	Non-Executive Director	37.6yrs	₹65.00k	1.37% ₹ 15.9m
Himanshu Jain	Non-Executive Director	20.9yrs	₹85.00k	0.91% ₹ 10.7m
Rishav Mehta	Non-Executive Director	14.3yrs	₹45.00k	0.21% ₹ 2.4m
Subhash Galhotra	Independent Director	7.6yrs	₹70.00k	keine Daten
Anoop Michra	Independent Woman Director	7.2yrs	₹55.00k	keine Daten
Jagvir Ahluwalia	Non-Executive Independent Director	6.9yrs	₹70.00k	keine Daten
Bhupinder Singh	Non-Executive Independent Director	2.1yrs	₹55.00k	keine Daten

16.0yrs

Durchschnittliche Betriebszugehörigkeit

66yo

Durchschnittliches Alter

Erfahrener Vorstand: 524652Die Vorstandsmitglieder sind sehr erfahren ( 15.8 ).

Ind-Swift Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Ind-Swift Limited Announces Cessation of Vinay Arora as an Independent Director

Ind-Swift Limited, Annual General Meeting, Sep 30, 2023

Insufficient new directors

Ind-Swift Approves Appointment of Sh. Bhupinder Singh as an Independent Director

Ind-Swift Limited, Annual General Meeting, Sep 21, 2022

Ind-Swift Limited Appoints Ginny Uppal as Company Secretary and Compliance Officer

Recent updates

New minor risk - Earnings quality

Full year 2024 earnings released: EPS: ₹2.63 (vs ₹4.81 in FY 2023)

Ind-Swift Limited to Report Q4, 2024 Results on May 14, 2024

Investor sentiment deteriorates as stock falls 16%

Investor sentiment improves as stock rises 29%

Investor sentiment improves as stock rises 21%

Ind-Swift Limited Announces Cessation of Vinay Arora as an Independent Director

Investor sentiment improves as stock rises 16%

Third quarter 2024 earnings released: ₹2.76 loss per share (vs ₹0.19 loss in 3Q 2023)

Investor sentiment improves as stock rises 18%

Ind-Swift Limited to Report Q3, 2024 Results on Feb 13, 2024

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 16%

Second quarter 2024 earnings released: ₹1.98 loss per share (vs ₹1.96 loss in 2Q 2023)

Ind-Swift Limited to Report Q2, 2024 Results on Nov 09, 2023

New major risk - Market cap size

Investor sentiment deteriorates as stock falls 16%

Ind-Swift Laboratories Limited (NSEI:INDSWFTLAB) agreed to acquire Ind-Swift Limited (BSE:524652).

Ind-Swift Laboratories Limited (NSEI:INDSWFTLAB) agreed to acquire Ind-Swift Limited (BSE:524652).

Ind-Swift Limited, Annual General Meeting, Sep 30, 2023

Investor sentiment improves as stock rises 21%

Investor sentiment improves as stock rises 21%

First quarter 2024 earnings released: EPS: ₹0.44 (vs ₹2.85 loss in 1Q 2023)

Ind-Swift Limited to Report Q1, 2024 Results on Aug 10, 2023

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

Full year 2023 earnings released: EPS: ₹4.81 (vs ₹3.70 loss in FY 2022)

Ind-Swift Limited to Report Q4, 2023 Results on May 30, 2023

Third quarter 2023 earnings released

Ind-Swift Limited to Report Q3, 2023 Results on Feb 13, 2023

Second quarter 2023 earnings released: ₹1.96 loss per share (vs ₹0.91 loss in 2Q 2022)

Insufficient new directors

Ind-Swift Limited to Report Q2, 2023 Results on Nov 14, 2022

Ind-Swift Approves Appointment of Sh. Bhupinder Singh as an Independent Director

First quarter 2023 earnings released: ₹2.85 loss per share (vs ₹0.66 loss in 1Q 2022)

Ind-Swift Limited, Annual General Meeting, Sep 21, 2022

Ind-Swift Limited to Report Q1, 2023 Results on Aug 09, 2022

Full year 2022 earnings released: ₹3.70 loss per share (vs ₹5.51 loss in FY 2021)

Ind-Swift Limited Appoints Ginny Uppal as Company Secretary and Compliance Officer

Ind-Swift Limited to Report Q4, 2022 Results on May 30, 2022

Less than half of directors are independent

Ind-Swift Limited Announces the Resignation of Amrender Kumar Yadav as Company Secretary & Compliance Officer

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Ind-Swift Limited to Report Q3, 2022 Results on Feb 14, 2022

First quarter 2022 earnings released: ₹0.66 loss per share (vs ₹1.64 loss in 1Q 2021)

ANG Lifesciences India Limited (BSE:540694) acquired Two Formulation Manufacturing Facilities from Ind-Swift Limited (BSE:524652) for INR 600 million.

Full year 2021 earnings released: ₹5.50 loss per share (vs ₹3.53 loss in FY 2020)

Third quarter 2021 earnings released: ₹0.22 loss per share (vs ₹2.18 loss in 3Q 2020)

Ind-Swift Limited to Report Q3, 2021 Results on Feb 13, 2021

New 90-day low: ₹3.01

Second quarter 2021 earnings released: ₹0.42 loss per share

New 90-day high: ₹3.59

New 90-day high - ₹3.50

Earnings released

Analyse der Geschäftsführervergütung

Geschäftsführer

Amtszeit

Vergütung

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter